An open-label randomised controlled trial evaluating the efficacy of a meningococcal serogroup B (4CMenB) vaccine on Neisseria gonorrhoeae infection in gay and bisexual men: the MenGO study protocol

Abstract Background Gonorrhoea is an ongoing public health concern due to its rising incidence and the emergence of antibiotic resistance. There are an estimated 82 million new Neisseria gonorrhoeae infections each year, with several populations at higher risk for gonococcal infection, including gay...

Descrición completa

Detalles Bibliográficos

Principais autores:	Caroline Thng, Evgeny A. Semchenko, Ian Hughes, Maree O’Sullivan, Kate L. Seib
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-03-01
Series:	BMC Public Health
Assuntos:	Gonorrhoea Neisseria gonorrhoeae Sexually transmitted infection (STI) Gay and bisexual men (GBM) Men who have sex with men (MSM) 4CMenB
Acceso en liña:	https://doi.org/10.1186/s12889-023-15516-y
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!